Open access · OA
via OpenAlex
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Zhennan Yuan, Yingpu Li, Sifan Zhang, Xueying Wang, He Dou, Yu Xi, Zhiren Zhang, Shanshan Yang, Min Xiao
Molecular Cancer · 2023 · ▲ 864 citations
Abstract
The malignant tumor is a multi-etiological, systemic and complex disease characterized by uncontrolled cell proliferation and distant metastasis. Anticancer treatments including adjuvant therapies and targeted therapies are effective in eliminating cancer cells but in a limited number of patients. Increasing evidence suggests that the extracellular matrix (ECM) plays an important role in tumor development through changes in macromolecule components, degradation enzymes and stiffness. These variations are under the control of cellular components in tumor tissue via the aberrant activation of signaling pathways, the interaction of the ECM components to multiple surface receptors, and mechanical impact. Additionally, the ECM shaped by cancer regulates immune cells which results in an immune suppressive microenvironment and hinders the efficacy of immunotherapies. Thus, the ECM acts as a barrier to protect cancer from treatments and supports tumor progression. Nevertheless, the profound regulatory network of the ECM remodeling hampers the design of individualized antitumor treatment. Here, we elaborate on the composition of the malignant ECM, and discuss the specific mechanisms of the ECM remodeling. Precisely, we highlight the impact of the ECM remodeling on tumor development, including proliferation, anoikis, metastasis, angiogenesis, lymphangiogenesis, and immune escape. Finally, we emphasize ECM "normalization" as a potential strategy for anti-malignant treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s12943-023-01744-8
- Canonical
- link ↗
- Fetched
- 2026-06-07 MST
Cite this
APA
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Xi, Y., Zhang, Z., Yang, S., & Xiao, M. (2023). Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. <em>Molecular Cancer</em>. https://doi.org/10.1186/s12943-023-01744-8
Vancouver
Yuan Z, Li Y, Zhang S, Wang X, Dou H, Xi Y, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Molecular Cancer. 2023. doi:10.1186/s12943-023-01744-8.
BibTeX
@article{zhennan2023Extrac,
title = {Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments},
author = {Zhennan Yuan and Yingpu Li and Sifan Zhang and Xueying Wang and He Dou and Yu Xi and Zhiren Zhang and Shanshan Yang and Min Xiao},
journal = {Molecular Cancer},
year = {2023},
doi = {10.1186/s12943-023-01744-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Hematology & Oncology 2022
Open access · CC-BY
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
International Journal of Molecular Sciences 2021
Open access · CC-BY
Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment
Frontiers in Immunology 2024
Open access · CC-BY
Extracellular matrix remodeling in the tumor immunity
Signal Transduction and Targeted Therapy 2021
Open access · CC-BY
Extracellular matrix and its therapeutic potential for cancer treatment
International Journal of Molecular Sciences 2024
Open access · CC-BY
Vascular Extracellular Matrix in Atherosclerosis
Biomimetics 2023
Open access · CC-BY